Sanofi Consumer Healthcare India Ltd
We wish to inform you that the Board of Directors at its meeting held today, i.e. Tuesday, 28th July 2026, inter alia considered and approved the Unaudited Financial Results for the quarter ....
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 28 Jul 2026, 07:41 PM IST · BSE ID: 238874b1-c1db-4191-9024-cdf4315a7994
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its latest financial performance, reporting Rs. 688 Million in profit for the recent quarter.
🤖 AI Summary
- Sanofi Consumer Healthcare India Board approved unaudited financial results for the quarter ended June 30, 2026.
- Revenue from Operations for the quarter ended June 30, 2026, was Rs. 2,357 Million.
- Profit for the quarter ended June 30, 2026, stood at Rs. 688 Million.
- Basic and diluted earnings per share for the quarter were Rs. 29.87.
- Half-year profit for the period ended June 30, 2026, was Rs. 1,366 Million.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Quarter ended 30.06.2026)
2,357 Million
6.70%
Profit for the period (Quarter ended 30.06.2026)
688 Million
13.34%
Basic and diluted earnings per share (Quarter ended 30.06.2026)
29.87 ₹
13.32%
Total comprehensive income (Half year ended 30.06.2026)
1,366 Million
23.39%
Cash and cash equivalents (As at June 30, 2026)
4,902 Million
🏢 How This Affects the Company
The company's profit for the quarter ended June 30, 2026, was Rs. 688 Million, contributing to a half-year profit of Rs. 1,366 Million. Cash and cash equivalents increased to Rs. 4,902 Million as of June 30, 2026, from Rs. 3,748 Million as of December 31, 2025.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, as reflected by the basic and diluted EPS of Rs. 29.87 for the quarter ended June 30, 2026.
🔍
Management Signal
The management's approval of the unaudited financial results indicates adherence to regulatory disclosure requirements and a commitment to transparency regarding performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor revenue and profit growth trend.
Investor calls/transcripts — look for management commentary on growth drivers.
Operating cash flow trends — check continued generation of cash.
LOW RISK
The filing indicates positive financial performance with increased revenue and profit.
💡 Investor Takeaway
Sanofi Consumer Healthcare India reported profit of Rs. 688 Million for the quarter ended June 30, 2026, an increase from Rs. 607 Million in Q1 FY26. Revenue from operations reached Rs. 2,357 Million for the quarter, up from Rs. 2,209 Million in the prior year comparable period.
⚖️ Strengths & Concerns
✅ Positives
- Profit for the period increased to Rs. 688 Million for Q1 FY27, up from Rs. 607 Million in the comparable prior year quarter.
- Revenue from operations grew to Rs. 2,357 Million for Q1 FY27, compared to Rs. 2,209 Million in Q1 FY26.
⚠️ Concerns
- Cost of materials consumed for Q1 FY27 was Rs. 475 Million, remaining a significant expense.
- Total current liabilities increased to Rs. 3,271 Million as of June 30, 2026, from Rs. 1,284 Million as of December 31, 2025.
📅 Company Track Record
In Q4 FY26, Sanofi Consumer Healthcare India reported a profit of Rs. 678 million, with domestic sales recovering 15.5% following product relaunches. Full-year FY26 profit stood at Rs. 2,401 million. These results continue to show consistent profitability and revenue growth.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Sanofi Consumer Healthcare India's revenue from operations for the quarter ended June 30, 2026?
Sanofi Consumer Healthcare India reported Revenue from Operations of Rs. 2,357 Million for the quarter ended June 30, 2026.
What was the profit for the period for Sanofi Consumer Healthcare India in Q1 FY27?
The profit for the period for Sanofi Consumer Healthcare India for the quarter ended June 30, 2026 (Q1 FY27) was Rs. 688 Million.
What were the basic and diluted earnings per share for Sanofi Consumer Healthcare India for the quarter ended June 30, 2026?
Basic and diluted earnings per share for Sanofi Consumer Healthcare India were Rs. 29.87 for the quarter ended June 30, 2026.
What was Sanofi Consumer Healthcare India's total comprehensive income for the half year ended June 30, 2026?
Sanofi Consumer Healthcare India's total comprehensive income for the half year ended June 30, 2026, was Rs. 1,366 Million.
What was the net cash inflow from operating activities for Sanofi Consumer Healthcare India for the half year ended June 30, 2026?
Net cash inflow from operating activities for Sanofi Consumer Healthcare India for the half year ended June 30, 2026, was Rs. 1,096 Million.
Questions based on this BSE filing only. For information purposes.